Honestly, I would need to know more about their strategy, partner, development plan before I could even speculate. Diabetes market is $58B. Watch how much a Big Pharma pays for Afrezza to benchmark how much a company is willing to pay for a new product in this market. I would bet you could see Afrezza get sold for $20B++.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links